Flat penile lesions: The infectious "invisible" link in the transmission of human papillomavirus

International Journal of Cancer

Volumn 119, Issue 11, 2006, Pages 2505-2512

  Bleeker, Maaike C G ^a   Snijders, Peter F J ^a   Voorhorst, Feja J ^a   Meijer, Chris J L M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Concordance; Condom use; Flat penile lesions; HPV; Sex partners; Sexual transmission; Vaccination; Viral load

Indexed keywords

ACETIC ACID; VIRUS DNA; WART VIRUS VACCINE;

CONDOM; CONDYLOMA; DNA DETERMINATION; FLAT PENIS LESION; HUMAN; IN SITU HYBRIDIZATION; NONHUMAN; PENIS DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEXUAL TRANSMISSION; SHORT SURVEY; VIRUS DETECTION; VIRUS LOAD; VIRUS TRANSMISSION; WART VIRUS;

DNA, VIRAL; HUMANS; IN SITU HYBRIDIZATION; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PENIS; SEXUAL BEHAVIOR; SEXUAL PARTNERS; VIRAL LOAD;

EID: 33750615578     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22209     Document Type: Short Survey

References (78)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijdeis PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide [see comments]. J Pathol 1999;189:12-19.
2. Rubin MA, Kleter B, Zhou M, Ayala G, Cubilla AL, Quint WG, Pirog EC. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 2001;159:1211-18.
3. Ferreux E, Lont AP, Horenblas S, Gallee MPW, Raaphorst FM, Doeberitz MV, Meijer CJLM, Snijders PJF. Evidence for at least three alternative mechanisms targeting the p16(INK4A)/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J Pathol 2003;201:109-18.
4. Gross G, Pfister H. Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol (Berl) 2004;193:35-44.
5. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, Carter JJ, Porter PL, Galloway DA, McDougall JK. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004;101:270-80.
6. Frisch M, Fenger C, van den Brule AJ, Sorensen P, Meijer O, Walboomers JM, Adami HO, Melbye M, Glimelius B. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res 1999;59:753-7.
7. Williams GR, Lu QL, Love SB, Talbot IC, Northover JM. Properties of HPV-positive and HPV-negative anal carcinomas. J Pathol 1996; 180:378-82.
8. Syrjanen K, Hakama M, Saarikoski S, Vayrynen M, Yliskoski M, Syrjanen S, Kataja V, Castren O. Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a non-selected finnish female population. Sex Transm Dis 1990;17:15-19.
9. Campion MJ, Singer A, Clarkson PK, McCance DJ. Increased risk of cervical neoplasia in consorts of men with penile condylomata acuminata. Lancet 1985;1:943-6.
10. Oriel JD. Natural history of genital warts. Br J Vener Dis 1971;47:1-13.
11. Iftner A, Klug SJ, Garbe C, Blum A, Stancu A, Wilczynski SP, Iftner T. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors. Cancer Res 2003;63: 7515-19.
12. Wieland U, Jurk S, Weissenborn S, Krieg T, Pfister H, Ritzkowsky A. Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol 2000;115:396-401.
13. Rosemberg SK, Reid R. Sexually transmitted papillomaviral infections in the male. I. Anatomic distribution and clinical features. Urology 1987;29:488-92.
14. Barrasso R, de Brux J, Croissant O, Orth G. High prevalence of papillomavirus-associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia. N Engl J Med 1987;317:916-23.
15. Campion MJ, McCance DJ, Mitchell HS, Jenkins D, Singer A, Oriel JD. Subclinical penile human papillomavirus infection and dysplasia in consorts of women with cervical neoplasia. Genitourin Med 1988;64:90-9.
16. Bistoletti P, Lidbrink P. Sexually transmitted diseases including genital papillomavirus infection in male sexual partners of women treated for cervical intraepithelial neoplasia III by conization. Br J Obstet Gynaecol 1988;95:611-13.
17. Kataoka A, Claesson U, Hansson BG, Eriksson M, Lindh E. Human papillomavirus infection of the male diagnosed by southern-blot hybridization and polymerase chain reaction: comparison between urethra samples and penile biopsy samples. J Med Virol 1991;33: 159-64.
18. Hippelainen M, Yliskoski M, Saarikoski S, Syrjanen S, Syrjanen K. Genital human papillomavirus lesions of the male sexual partners: the diagnostic accuracy of peniscopy [see comments]. Genitourin Med 1991;67:291-6.
19. Barrasso R. HPV-related genital lesions in men. IARC Sci Publ 1992;(119):85-92.
20. Bergman A, Nalick R. Prevalence of human papillomavirus infection in men. comparison of the partners of infected and uninfected women. J Reprod Med 1992;37:710-12.
21. Tabrizi SN, Tan J, Quinn M, Borg AJ, Garland SM. Detection of genital human papillomavirus (HPV) DNA by PCR and other conventional hybridisation techniques in male partners of women with abnormal papanicolaou smears. Genitourin Med 1992;68:370-3.
22. Kokelj F, Baraggino E, Stinco G, Wiesenfeld U. Study of the partners of women with human papillomavirus infection. Int J Dermatol 1993; 32:661-3.
23. Rotola A, Costa S, Monini P, Vendra C, Guida G, Terzano P, Di Luca D, Martinelli G, Cassai E. Impact of sexual habits on the clinical evaluation of male HPV infection. Eur J Epidemiol 1994;10:373-80.
24. Maymon R, Bekerman A, Werchow M, Maymon BB, Segal R, Faktor JH. Clinical and subclinical condyloma. Rates among male sexual partners of women with genital human papillomavirus infection. J Reprod Med 1995;40:31-6.
25. Bar-Am A, Niv J, Jaffo A, Peyser RM. Prevalence of human papillomavirus infection and HPV DNA among male partners of Israeli women with genital premalignant and human papillomavirus lesions. Isr J Med Sci 1995;31:349-52.
26. Palefsky JM, Barrasso R. HPV infection and disease in men. Obstet Gynecol Clin North Am 1996;23:895-916.
27. Pakendorf UW, Bornman MS, Du Plessis DJ. Prevalence of human papilloma virus in men attending the infertility clinic. Andrologia 1998; 30:11-14.
28. Frega A, Stentella P, Villani C, Di Ruzza D, Marcomin GL, Rota F, Boninfante M, Pachi A. Correlation between cervical intraepithelial neoplasia and human papillomavirus male infections: a longitudinal study. Eur J Gynaecol Oncol 1999;20:228-30.
29. Rosenblatt C, Lucon AM, Pereyra EA, Pinotti JA, Arap S, Ruiz CA. HPV prevalence among partners of women with cervical intraepithelial neoplasia. Int J Gynaecol Obstet 2004;84:156-61.
30. Hippelainen MI, Syrjanen S, Hippelainen MJ, Saarikoski S, Syrjanen K. Diagnosis of genital human papillomavirus (HPV) lesions in the male: correlation of peniscopy, histology and in situ hybridisation [see comments]. Genitourin Med 1993;69:346-51.
31. Wikstrom A, Hedblad MA, Johansson B, Kalantari M, Syrjanen S, Lindberg M, von Krogh G. The acetic acid test in evaluation of subclinical genital papillomavirus infection: a comparative study on penoscopy, histopathology, virology and scanning electron microscopy findings. Genitourin Med 1992;68:90-9.
32. Bleeker MC, Hogewoning CJ, van den Brule AJ, Voorhorst FJ, Van Andel RE, Risse EK, Starink TM, Meijer CJ. Penile lesions and human papillomavirus in male sexual partners of women with cervical intraepithelial neoplasia. J Am Acad Dermatol 2002;47:351-7.
33. Bleeker MC, Hogewoning CJ, Voorhorst FJ, van den Brule AJ, Berkhof J, Hesselink AT, Lettink M, Starink TM, Stoof TJ, Snijders PJ, Meijer CJ. HPV-associated flat penile lesions in men of a non-STD hospital population: less frequent and smaller in size than in male sexual partners of women with CIN. Int J Cancer 2005;33:36-41.
34. Hogewoning CJ, Bleeker MC, van den Brule AJ, Voorhorst FJ, Van Andel RE, Risse EK, Starink TM, Meijer CJ. Pearly penile papules: still no reason for uneasiness. J Am Acad Dermatol 2003;49:50-4.
35. Hogewoning CJ, Bleeker MC, van den Brule AJ, Voorhorst FJ, Snijders PJ, Berkhof J, Westenend PJ, Meijer O. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer 2003;107:811-16.
36. Bleeker MC, Hogewoning CJ, Voorhorst FJ, van den Brule AJ, Snijders PJ, Starink TM, Berkhof J, Meijer CJ. Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia. Int J Cancer 2003;107:804-10.
37. Bleeker MC, Hogewoning CJ, Berkhof J, Voorhorst F, Hesselink AT, van Diemen PM, van den Brule AJ, Snijders PJ, Meijer CJ. Type-specific human papillomavirus concordance between sexual partners is more prevalent than expected by chance and associated with increased viral loads. Clin Infect Dis 2005;41:612-20.
38. Bleeker MC, Berkhof J, Hogewoning CJ, Voorhorst FJ, van den Brule AJ, Starink TM, Snijders PJ, Meijer CJ. HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions. Br J Cancer 2005;92:1388-92.
39. Hippelainen MI, Yliskoski M, Syrjanen S, Saastamoinen J, Hippelainen M, Saarikoski S, Syrjanen K. Low concordance of genital human papillomavirus (HPV) lesions and viral types in HPV-infected women and their male sexual partners. Sex Transm Dis 1994;21:76-82.
40. Rehbein HM. Pearly penile papules: incidence. Cutis 1977;19:54-7.
41. Ferenczy A, Richart RM, Wright TC. Pearly penile papules: absence of human papillomavirus DNA by the polymerase chain reaction. Obstet Gynecol 1991;78:118-22.
42. Hippelainen M, Syrjanen S, Hippelainen M, Koskela H, Pulkkinen J, Saarikoski S, Syrjanen K. Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts. Sex Transm Dis 1993;20:321-8.
43. Gross G, Barrasso R. Human papilloma virus infection: a clinical atlas. Berlin: Ullstein Mosby, 1997.
44. Barrasso R. Latent and subclinical HPV external anogenital infection. Clin Dermatol 1997;15:349-53.
45. Weaver BA, Feng Q, Holmes KK, Kiviat N, Lee SK, Meyer C, Stern M, Koutsky LA. Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis 2004;189:677-85.
46. Aguilar LV, Lazcano-Ponce E, Vaccarella S, Cruz A, Hernandez P, Smith JS, Munoz N, Kornegay JR, Hernandez-Avila M, Franceschi S. Human papillomavirus in men: comparison of different genital sites. Sex Transm Infect 2006;82:31-3.
47. von Krogh G, Horenblas SN. Diagnosis and clinical presentation of premalignant lesions of the penis. Scand J Urol Nephrol 2000;34: 201-14.
48. Aynaud O, Ionesco M, Barrasso R. Penile intraepithelial neoplasia. Specific clinical features correlate with histologic and virologic findings. Cancer 1994;74:1762-7.
49. Sufrin G, Huben R. Benign and malignant lesions of the penis. In: Gillenwater JY, ed. Adult and pediatric urology, 2 edn. Chicago: Year Book Medical Publisher, 1991. Chapter 43.
50. Horenblas S, von Krogh G, Cubilla AL, Dillner J, Meijer CJ, Hedlund PO. Squamous cell carcinoma of the penis: premalignant lesions. Scand J Urol Nephrol Suppl 2000;34(Suppl 205): 187, 188.
51. Franceschi S, Castellsague X, Dal Maso L, Smith JS, Plummer M, Ngelangel C, Chichareon S, Eluf-Neto J, Shah KV, Snijders PJ, Meijer CJ, Bosch FX, et al. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer 2002;86:705-11.
52. Wickenden C, Hanna N, Taylor-Robinson D, Harris JR, Bellamy C, Carroll P, Malcolm AD, Coleman DV. Sexual transmission of human papillomaviruses in heterosexual and male homosexual couples, studied by DNA hybridisation. Genitourin Med 1988;64:34-8.
53. Kiss M, Husz S, Soos J, Dobozy A. Papillomavirus DNA typing analysis in condyloma acuminatum patients and their consorts. Acta Derm Venereol 1993;73:352-5.
54. Ho L, Tay SK, Chan SY, Bernard HU. Sequence variants of human papillomavirus type 16 from couples suggest sexual transmission with low infectivity and polyclonality in genital neoplasia. J Infect Dis 1993;168:803-9.
55. Kyo S, Inoue M, Koyama M, Fujita M, Tanizawa O, Hakura A. Detection of high-risk human papillomavirus in the cervix and semen of sex partners. J Infect Dis 1994;170:682-5.
56. Strand A, Rylander E, Wilander E, Zehbe I. HPV infection in male partners of women with squamous intraepithelial neoplasia and/or high-risk HPV. Acta Derm Venereol 1995;75:312-16.
57. Baken LA, Koutsky LA, Kuypers J, Kosorok MR, Lee SK, Kiviat NB, Holmes KK. Genital human papillomavirus infection among male and female sex partners: prevalence and type-specific concordance. J Infect Dis 1995;171:429-32.
58. Castellsague X, Ghaffari A, Daniel RW, Bosch FX, Munoz N, Shah KV. Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis 1997;176:353-61.
59. Gomousa-Michael M, Deligeorgi-Politi H, Condi-Paphiti A, Rammou-Kinia R, Ghionis I, Belca-Hari K. Human papillomavirus identification and typing of both sexual partners. Acta Cytol 1997;41: 244-50.
60. Nicolau SM, Camargo CG, Stavale IN, Castelo A, Dores GB, Lorincz A, de Lima GR. Human papillomavirus DNA detection in male sexual partners of women with genital human papillomavirus infection. Urology 2005;65:251-5.
61. Snijders PJ, van den Brule AJ, Meijer CJ. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol 2003;201:1-6.
62. van Duin M, Snijders PI, Schrijnemakers HF, Voorhorst FJ, Rozendaal L, Nobbenhuis MA, van den Brule AI, Verheijen RH, Helmerhorst TJ, Meijer CJ. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer 2002;98:590-5.
63. Moberg M, Gustavsson I, Wilander E, Gyllensten U. High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br J Cancer 2005;92:891-4.
64. Flores R, Papenfuss M, Klimecki WT, Giuliano AR. Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia. Int J Cancer 2006;118:1187-93.
65. Josefsson AM, Magnusson PK, Ylitalo N, Sorensen P, Qwarforth-Tubbin P, Andersen PK, Melbye M, Adami HO, Gyllensten UB. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study [see comments]. Lancet 2000;355:2189-93.
66. Snijders PJ, Hogewoning CI, Hesselink AT, Berkhof I, Voorhorst FJ, Bleeker MC, Meijer CJ. Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology. Int J Cancer 2006;119:1102-7.
67. Hippelainen MI, Hippelainen M, Saarikoski S, Syrjanen K. Clinical course and prognostic factors of human papillomavirus infections in men. Sex Transm Dis 1994;21:272-9.
68. Wen LM, Estcourt CS, Simpson JM, Mindel A. Risk factors for the acquisition of genital warts: are condoms protective? Sex Transm Infect 1999;75:312-16.
69. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? a meta-analysis. Sex Transm Dis 2002;29:725-35.
70. Carrington M, Wang S, Martin MP, Gao X, Schiffman M, Cheng J, Herrero R, Rodriguez AC, Kurman R, Mortel R, Schwartz P, Glass A, et al. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med 2005;201:1069-75.
71. Slavinsky J, Kissinger P, Burger L, Boley A, DiCarlo RP, Hagensee ME. Seroepidemiology of low and high oncogenic risk types of human papillomavirus in a predominantly male cohort of STD clinic patients. Int J STD AIDS 2001;12:516-23.
72. Svare EI, Kjaer SK, Nonnenmacher B, Worm AM, Moi H, Christensen RB, van den Brule AJ, Walboomers JM, Meijer CJ, Hubbert NL, Lowy DR, Schiller JT. Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women. J Infect Dis 1997;176:876-83.
73. Skegg DC, Corwin PA, Paul C, Doll R. Importance of the male factor in cancer of the cervix. Lancet 1982;2:581-3.
74. Castellsague X, Bosch FX, Munoz N, Meijer CJ, Shah KV, de Sanjose S, Eluf-Neto J, Ngelangel CA, Chichareon S, Smith JS, Herrero R, Moreno V, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002; 346:1105-12.
75. Castellsague X, Bosch FX, Munoz N. The male role in cervical cancer. Salud Publica Mex 2003;45(Suppl 3):S345-S353.
76. Partridge JM, Koutsky LA. Genital human papillomavirus infection in men. Lancet Infect Dis 2006;6:21-31.
77. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347:1645-51.
78. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin O. Sustained efficacy up to 4.5 years of a bivalent 11 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006;367:1247-55.